# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-12-159014
Filing Date
2012-04-11
Accepted
2012-04-11 17:03:55
Documents
33
Period of Report
2012-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d332424d8k.htm | 8-K | 14714
2 | CORPORATE UPDATE PRESENTATION SLIDES | d332424dex991.htm | EX-99.1 | 220944
3 | GRAPHIC | g332424ex99_1s10gbgd.jpg | GRAPHIC | 67682
4 | GRAPHIC | g332424ex99_1s11gbgd.jpg | GRAPHIC | 45808
5 | GRAPHIC | g332424ex99_1s12gbgd.jpg | GRAPHIC | 39715
6 | GRAPHIC | g332424ex99_1s13gbgd.jpg | GRAPHIC | 58929
7 | GRAPHIC | g332424ex99_1s14gbgd.jpg | GRAPHIC | 22698
8 | GRAPHIC | g332424ex99_1s15gbgd.jpg | GRAPHIC | 62085
9 | GRAPHIC | g332424ex99_1s16gbgd.jpg | GRAPHIC | 34160
10 | GRAPHIC | g332424ex99_1s17gbgd.jpg | GRAPHIC | 22698
11 | GRAPHIC | g332424ex99_1s18gbgd.jpg | GRAPHIC | 22698
12 | GRAPHIC | g332424ex99_1s19gbgd.jpg | GRAPHIC | 22698
13 | GRAPHIC | g332424ex99_1s1gbgd.jpg | GRAPHIC | 41641
14 | GRAPHIC | g332424ex99_1s20gbgd.jpg | GRAPHIC | 41222
15 | GRAPHIC | g332424ex99_1s21gbgd.jpg | GRAPHIC | 24540
16 | GRAPHIC | g332424ex99_1s22gbgd.jpg | GRAPHIC | 71677
17 | GRAPHIC | g332424ex99_1s23gbgd.jpg | GRAPHIC | 84710
18 | GRAPHIC | g332424ex99_1s24gbgd.jpg | GRAPHIC | 54608
19 | GRAPHIC | g332424ex99_1s25gbgd.jpg | GRAPHIC | 73449
20 | GRAPHIC | g332424ex99_1s26gbgd.jpg | GRAPHIC | 52497
21 | GRAPHIC | g332424ex99_1s27gbgd.jpg | GRAPHIC | 45135
22 | GRAPHIC | g332424ex99_1s28gbgd.jpg | GRAPHIC | 41397
23 | GRAPHIC | g332424ex99_1s29gbgd.jpg | GRAPHIC | 22698
24 | GRAPHIC | g332424ex99_1s2gbgd.jpg | GRAPHIC | 22698
25 | GRAPHIC | g332424ex99_1s30gbgd.jpg | GRAPHIC | 22698
26 | GRAPHIC | g332424ex99_1s31gbgd.jpg | GRAPHIC | 33355
27 | GRAPHIC | g332424ex99_1s3gbgd.jpg | GRAPHIC | 33904
28 | GRAPHIC | g332424ex99_1s4gbgd.jpg | GRAPHIC | 34127
29 | GRAPHIC | g332424ex99_1s5gbgd.jpg | GRAPHIC | 22698
30 | GRAPHIC | g332424ex99_1s6gbgd.jpg | GRAPHIC | 50260
31 | GRAPHIC | g332424ex99_1s7gbgd.jpg | GRAPHIC | 40885
32 | GRAPHIC | g332424ex99_1s8gbgd.jpg | GRAPHIC | 22698
33 | GRAPHIC | g332424ex99_1s9gbgd.jpg | GRAPHIC | 22698
| Complete submission text file | 0001193125-12-159014.txt |  | 1976213

Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 12754752
SIC: 2834 Pharmaceutical Preparations